Randhawa Simrat
EVP, Head of R&D at DNTH
- Sold, on record
- $15M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Sep 1, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DNTHDianthus Therapeutics, Inc. /DE/EVP, Head of R&D
Sales by reason
3
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale DNTHRoutineNov 14 2025
Sold 196,538 shares at $37.55 ($7.4M)
Randhawa Simrat, EVP, Head of R&D
10b5-1 planSold 98% of holdings ($7.5M position)4,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale DNTHRoutineMar 12 +118 days
Sold 33,830 shares at $81.48 ($2.8M)
Randhawa Simrat, EVP, Head of R&D
10b5-1 planSold 100% of holdings ($2.8M position)0 shares leftFiling
- 3 Form 4 sale DNTHRoutineJun 1 +81 days
Sold 26,530 shares at $90.62 ($2.4M)
Randhawa Simrat, EVP, Head of R&D
10b5-1 planSold 86.9% of holdings ($2.8M position)4,000 shares leftFiling
- 4 Form 4 sale DNTHRoutineSep 1 +92 days
Sold 23,124 shares at $106.41 ($2.5M)
Randhawa Simrat, EVP, Head of R&D
10b5-1 planSold 85.3% of holdings ($2.9M position)4,000 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | DNTH | EVP, Head of R&D | Form 4 sale | 23,124 | $2.5M | 85.3% | Routine | SEC |
| Jun 1, 2026 | DNTH | EVP, Head of R&D | Form 4 sale | 26,530 | $2.4M | 86.9% | Routine | SEC |
| Mar 12, 2026 | DNTH | EVP, Head of R&D | Form 4 sale | 33,830 | $2.8M | 100.0% | Routine | SEC |
| Nov 14, 2025 | DNTH | EVP, Head of R&D | Form 4 sale | 196,538 | $7.4M | 98.0% | Routine | SEC |